Evidence map›Paper›PMID 38937269›Full record

ArticleInterdisciplinary cardiovascular and thoracic surgery2024

Epicardial and endocardial surgical ablation of atrial fibrillation: outcomes from CASE-AF Registry.

Ivana Mitrovic, Edgar Eszlari, Adi Cvorak, Andreas Liebold, Ardawan Rastan, Herko Grubitzsch, Michael Knaut, Theodor Fischlein, Taoufik Ouarrak, Jochen Senges and 3 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Interdisciplinary cardiovascular and thoracic surgery, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Ivana MitrovicDepartment of Cardiac Surgery, Munich Clinic Bogenhausen, Munich, Germany.
Edgar EszlariDepartment of Cardiac Surgery, Munich Clinic Bogenhausen, Munich, Germany.
Adi CvorakDepartment of Cardiac Surgery, Munich Clinic Bogenhausen, Munich, Germany.
Andreas LieboldDepartment of Cardiothoracic and Vascular Surgery, Ulm University Hospital, Ulm, Germany.
Ardawan RastanDepartment of Cardiothoracic and Vascular Surgery, Philipps-University Hospital, Marburg, Germany.
Herko GrubitzschDepartment of Cardiothoracic and Vascular Surgery, Charite University Hospital, Berlin, Germany.
Michael KnautDepartment of Cardiac Surgery, University Hospital Carl Gustav Carus, Dresden, Germany.
Theodor FischleinDepartment of Cardiac Surgery, Nuremberg Clinic, Paracelsus Medical University, Nuremberg, Germany.ORCID 0000-0001-9781-3590
Taoufik OuarrakInstitute for Heart Attack Research, Ludwigshafen, Germany.ORCID 0000-0001-7742-4408
Jochen SengesInstitute for Heart Attack Research, Ludwigshafen, Germany.
Thorsten HankeDepartment of Cardiac Surgery, Asklepios Clinic Harburg, Hamburg, Germany.
Nicolas DollDepartment of Cardiac Surgery, Schuechtermann-Clinic, Bad Rothenfelde, Germany.
Walter EichingerDepartment of Cardiac Surgery, Munich Clinic Bogenhausen, Munich, Germany.

Funding

Atricure Europe BV
6 · The paper itself

Abstract

objectivesThe German CArdioSurgEry Atrial Fibrillation Registry is a prospective, multicentric registry analysing outcomes of patients undergoing surgical ablation for atrial fibrillation as concomitant or stand-alone procedures. This data sub-analysis of the German CArdioSurgEry Atrial Fibrillation Registry aims to describe the in-hospital and 1-year outcomes after concomitant surgical ablation, based on 2 different ablation approaches, epicardial and endocardial surgical ablation.

methodsBetween January 2017 and April 2020, 17 German cardiosurgical units enrolled 763 consecutive patients after concomitant surgical ablation. In the epicardial group, 413 patients (54.1%), 95.6% underwent radiofrequency ablation. In the endocardial group, 350 patients (45.9%), 97.7% underwent cryoablation. 61.5% of patients in the epicardial group and 49.4% of patients in the endocardial group presenting with paroxysmal atrial fibrillation. Pre-, intra- and post-operative data were gathered.

resultsUpon discharge, 32.3% (n = 109) of patients after epicardial surgical ablation and 24.0% (n = 72) of patients after endocardial surgical ablation showed recurrence of atrial fibrillation. The in-hospital mortality rate was low, 2.2% (n = 9) in the epicardial and 2.9% (n = 10) in the endocardial group. The overall 1-year procedural success rate was 58.4% in the epicardial and 62.2% in the endocardial group, with significant symptom improvement in both groups. The 1-year mortality rate was 7.7% (n = 30) in epicardial and 5.0% (n = 17) in the endocardial group.

conclusionsConcomitant surgical ablation is safe and effective with significant improvement in patient symptoms and freedom from atrial fibrillation. Adequate cardiac rhythm monitoring should be prioritized for higher quality data acquisition.

Indexed as

Atrial fibrillationConcomitant surgical ablationCryoablationRadiofrequency

Identifiers

PMID38937269
PMCPMC11246162

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.